Clinical trial
Direct Antiviral Agents for the Treatment of Chronic HCV/HBV Co-infection Patients
NCT02555943 is registered in ClinicalTrials.gov with Humanity and Health Research Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Direct Antiviral Agents for the Treatment of Chronic HCV/HBV Co-infection Patients
- Lead sponsor
- Humanity and Health Research Centre
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- August 31, 2021
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic hepatitis c infection, hbv coinfection, hepatitis b reactivation